STAT

With the Nobel Prizes around the corner, it’s crystal ball time

The scientists who pioneered immunotherapy and other cancer advances are among the favorites for this year's Nobel Prizes, which will be announced the first week of October.

Really, we at STAT love autophagy, the cell’s garbage disposal. Also those adorable little molecular machines. Discoveries about the former won the Nobel Prize in medicine last year for Yoshinori Ohsumi, while three inventors of the latter won the chemistry prize. But if Bob Dylan can win the literature Nobel, can science Nobels go to researchers whose work has a contemporary flair and direct relevance to what matters to the public?

We’re looking at you, Jim Allison of MD Anderson Cancer Center, Gordon Freeman of Dana-Farber Cancer Institute, and Dr. Arlene Sharpe of Harvard Medical School — or, we think the Nobel Committee choosing the medicine

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Eli Lilly’s Anti-vanity Ad Campaign For Oscars
Eli Lilly will be unveiling a new campaign during this weekend’s Oscar awards event, with a clear message: These drugs aren’t meant to be used for cosmetic reasons. "It matters…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Congress Punts PBM Reform, Another Obesity Drug And More
BioMarin Pharmaceutical received a subpoena from the U.S. Department of Justice seeking information about the sponsored testing programs.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Weight Loss Drugs, A Cell Therapy For Melanoma, And More
China has more obese people than anywhere else in the world, and they are increasingly turning to weight loss drugs, fueling a gray market.

Related